caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1720066996

Robyn Nebergall

PRACTICEST LUKE'S JONES REGIONAL MEDICAL CENTERSee all providers at this practice →
Physician AssistantTipton, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Robyn Nebergall's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Medical Laboratories Of Eastern Iowa Lc
Clinical Laboratory · Cedar Rapids, IA
124615
ST LUKE'S METHODIST HOSPITAL41222
WILLEY, LINDSEY1641
Steven Craig
Podiatry · Midvale, UT
1524
STATE UNIVERSITY OF IOWA1588
SPEIGNER, DARLA1125
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,086
Beneficiaries
—
Total drug cost
$373K
Distinct drugs
74
Brand share
18.8%
Top prescribed drugs
Atorvastatin Calcium374 claims
Omeprazole257 claims
Lisinopril224 claims
Rosuvastatin Calcium218 claims
Levothyroxine Sodium176 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.